インプラント周囲炎市場 - 世界の産業規模、シェア、動向、機会、予測、タイプ別（非外科的、外科的）、エンドユーザー別（歯科医院、病院）、地域別、競合別、2020年～2030年

インプラント周囲炎の世界市場規模は、2024年に11億580万米ドルとなり、2030年までのCAGRは8.15%で、予測期間中に目覚ましい成長が見込まれています。

インプラント周囲炎は、歯科インプラント周囲の組織に影響を及ぼす炎症性疾患です。天然歯の周囲組織を侵す炎症性疾患である歯周炎とやや類似しています。インプラント周囲炎は、特にインプラント周囲の軟組織と硬組織に炎症と感染を引き起こし、インプラントを支える骨の損失を進行させ、放置するとインプラントの失敗につながる可能性があります。インプラント周囲炎の一般的な徴候や症状には、歯茎の出血、腫れ、発赤、膿の排出、インプラント周囲の痛みや不快感、インプラントの可動性や緩み、進行すると目に見える歯茎の退縮やインプラントの糸の露出などがあります。インプラント周囲炎の開発には、口腔衛生状態の悪化、喫煙、歯周病（歯茎の病気）の既往歴、糖尿病、特定の薬、定期的な歯科検診やメンテナンスの不足など、いくつかの要因がリスクを高める可能性があります。インプラント周囲炎は、インプラント周囲の組織や骨の損失の程度により、軽度から重度までの段階に分類されることが多いです。インプラント周囲炎を効果的に管理するには、早期発見と介入が重要です。

主要な市場促進要因

インプラント周囲炎疾患の増加

主要な市場課題

治療費

主要な市場動向

治療モダリティ

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 インプラント周囲炎市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（非外科的、外科的）
  • エンドユーザー別（歯科医院、病院）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米のインプラント周囲炎市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のインプラント周囲炎市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋のインプラント周囲炎市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のインプラント周囲炎市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのインプラント周囲炎市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界のインプラント周囲炎市場：SWOT分析

第14章 競合情勢

• Pfizer Inc.
• Cadila Pharmaceuticals Ltd.
• R.N. Laboratories Pvt. Ltd.
• Basic Pharma Life Science Pvt. Ltd
• Prachi Pharmaceuticals Private Limited
• Geistlich Pharma Inc.
• Healthy Life Pharma.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Peri-implantitis Market was valued at USD 1105.80 Million in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.15% through 2030. Peri-implantitis is an inflammatory condition that affects the tissues surrounding dental implants. It is somewhat analogous to periodontitis, which is an inflammatory disease that affects the tissues surrounding natural teeth. Peri-implantitis specifically involves the inflammation and infection of the soft and hard tissues around a dental implant, which can lead to progressive loss of supporting bone and potentially result in implant failure if left untreated. Common signs and symptoms of peri-implantitis may include bleeding gums, swelling, redness, pus discharge, pain or discomfort around the implant, mobility or loosening of the implant, and, in advanced cases, visible gum recession and exposed implant threads. Several factors can increase the risk of developing peri-implantitis, including poor oral hygiene, smoking, a history of periodontal disease (gum disease), diabetes, certain medications, and a lack of regular dental check-ups and maintenance. Peri-implantitis is often categorized into stages, ranging from mild to severe, based on the extent of tissue and bone loss around the implant. Early detection and intervention are crucial for managing peri-implantitis effectively.

Key Market Drivers

Rising Prevalence of Peri-implant Diseases

The rising prevalence of peri-implant diseases is a critical market driver that significantly influences the growth of the Global Peri-implantitis Market. Research indicates that peri-implantitis affects approximately 7% to 28% of patients with dental implants, while peri-implant mucositis is observed in 27% to 63% of cases. Although the World Health Organization (WHO) has not established specific guidelines on peri-implant disease incidence, its initiatives emphasize overall oral health management and the importance of preventive care in implant dentistry. Peri-implant diseases, including peri-implant mucositis and peri-implantitis, are becoming increasingly common due to the widespread adoption of dental implants. This growing burden has created a rising demand for preventive, diagnostic, and treatment solutions, fueling market expansion. The global surge in dental implant procedures has led to a proportional increase in peri-implant diseases. While dental implants are a preferred solution for tooth replacement due to their durability and functionality, they are also susceptible to infection and inflammation, which can lead to peri-implant diseases. The more implants placed, the higher the number of patients experiencing peri-implant conditions, thereby driving the demand for effective peri-implantitis treatment solutions.

Key Market Challenges

Cost of Treatment

Peri-implantitis treatment can be costly, particularly in cases where surgical interventions, such as open flap debridement, bone grafting, or implant removal and replacement, are required. The expenses associated with these procedures, including professional fees, facility charges, and post-operative care, can add up quickly. Dental insurance plans often do not provide comprehensive coverage for peri-implantitis treatment. This lack of coverage can place a significant financial burden on patients, making treatment less accessible. Many peri-implantitis treatment expenses are out-of-pocket costs for patients. This includes the cost of diagnostic tests, consultations with specialists, surgical procedures, medications, and follow-up care. Peri-implantitis treatment may require multiple treatment sessions and follow-up appointments, which can further increase the overall cost for patients. The cost of peri-implantitis treatment can vary widely depending on the severity of the condition, the complexity of the procedures required, the geographic location of the dental practice, and the expertise of the treating professionals. Patients with limited financial resources may find it challenging to afford the upfront costs associated with peri-implantitis treatment. This can lead to delays in seeking care or a reluctance to pursue treatment altogether. High treatment costs can have a significant impact on the quality of life of patients with peri-implantitis. They may have to make difficult choices between their oral health and other essential expenses. Patients in underserved or remote areas may have limited access to specialized dental professionals with expertise in peri-implantitis treatment. Traveling long distances to seek care can add to the overall cost.

Key Market Trends

Treatment Modalities

Surgical treatment modalities, such as open flap debridement, bone grafting, and guided tissue regeneration, continue to be prominent in peri-implantitis management. Advancements in surgical techniques and materials enhance their effectiveness. Laser technology, including diode lasers and erbium lasers, has gained popularity for the treatment of peri-implantitis. Lasers can effectively remove infected tissue, disinfect implant surfaces, and promote tissue regeneration. Various antimicrobial agents, including topical antibiotics and antiseptics, are used in the treatment of peri-implantitis to control bacterial infections. Research is ongoing to develop more targeted and effective antimicrobial treatments. Implantoplasty involves the mechanical smoothing of rough implant surfaces to remove biofilm and encourage re-osseointegration. This minimally invasive approach is gaining attention as a potential treatment option. Non-surgical modalities, such as mechanical debridement and air abrasive therapy, are considered for less severe cases of peri-implantitis. These methods aim to remove biofilm and calculus without the need for surgical intervention. Personalized treatment plans based on the specific needs of each patient are becoming more common. This includes considering factors like the extent of tissue loss, bone quality, and patient health status. Biomaterials, growth factors, and tissue engineering scaffolds are being explored to enhance tissue regeneration around dental implants affected by peri-implantitis. Telehealth platforms and teledentistry services are being utilized for remote consultations, monitoring, and follow-up care, making peri-implantitis treatment more accessible to patients. Research into smart implants with integrated sensors and monitoring capabilities is ongoing. These implants may provide real-time data on the health of the implant and surrounding tissues, aiding in treatment decisions.

Key Market Players

• Pfizer Inc.
• Cadila Pharmaceuticals Ltd.
• R.N. Laboratories Pvt. Ltd.
• Basic Pharma Life Science Pvt. Ltd
• Prachi Pharmaceuticals Private Limited
• Geistlich Pharma Inc.
• Healthy Life Pharma

Report Scope:

In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peri-implantitis Market, By Type:

• Non-Surgical
• Surgical

Peri-implantitis Market, By End-User:

• Dental Clinics
• Hospitals

Peri-implantitis Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.

Available Customizations:

Global Peri-implantitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Peri-implantitis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Non-Surgical, Surgical)
  • 5.2.2. By End-User (Dental Clinics, Hospitals)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Peri-implantitis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Peri-implantitis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Peri-implantitis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Peri-implantitis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Peri-implantitis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Peri-implantitis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Peri-implantitis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Peri-implantitis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Peri-implantitis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Peri-implantitis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Peri-implantitis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Peri-implantitis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Peri-implantitis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Peri-implantitis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Peri-implantitis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Peri-implantitis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America Peri-implantitis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Peri-implantitis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Peri-implantitis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Peri-implantitis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Peri-implantitis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Peri-implantitis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Peri-implantitis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Peri-implantitis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Peri-implantitis Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Pfizer Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cadila Pharmaceuticals Ltd.
• 14.3. R.N. Laboratories Pvt. Ltd.
• 14.4. Basic Pharma Life Science Pvt. Ltd
• 14.5. Prachi Pharmaceuticals Private Limited
• 14.6. Geistlich Pharma Inc.
• 14.7. Healthy Life Pharma.

15. Strategic Recommendations

16. About Us & Disclaimer